JP2002114703A - Antioxidant - Google Patents

Antioxidant

Info

Publication number
JP2002114703A
JP2002114703A JP2000307367A JP2000307367A JP2002114703A JP 2002114703 A JP2002114703 A JP 2002114703A JP 2000307367 A JP2000307367 A JP 2000307367A JP 2000307367 A JP2000307367 A JP 2000307367A JP 2002114703 A JP2002114703 A JP 2002114703A
Authority
JP
Japan
Prior art keywords
antioxidant
green algae
cell green
chlorella
lipid peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000307367A
Other languages
Japanese (ja)
Inventor
Mikio Nishikawa
三喜男 西川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamaki KK
Original Assignee
Yamaki KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamaki KK filed Critical Yamaki KK
Priority to JP2000307367A priority Critical patent/JP2002114703A/en
Publication of JP2002114703A publication Critical patent/JP2002114703A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an antioxidant safety, stable and easy to use. SOLUTION: This antioxidant comprises phycobiont or its extract of a unicellular Chlorophyceae such as Chlorella, Scenedesmus or Chlamydomonas or he like cultured in a dark and a heterotrophic condition. The antioxidant is cpable of suppressing production of lipoperoxide in low density lipoprotein(LDL) of serum, harmless and capable of carrying out an ingestion, usable for doods, medicines, cosmetics and their additives.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、抗酸化作用を有
し、食品および医薬品等に広く利用できる材料に関する
ものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a material which has an antioxidant effect and can be widely used in foods and pharmaceuticals.

【0002】[0002]

【従来の技術】一般に天然物由来の抗酸化物質として
は、例えば、トコフェロール類(ビタミンE)がよく知
られており、現在、医薬品、食品またはこれらの添加物
として広く利用されている。しかしながら、トコフェロ
ール類は脂溶性で、この物質自体が油状を呈しているこ
とから、その利用態様は油脂類への添加や、ゼラチンカ
プセル等に限られている。また、このような抗酸化作用
を示す物質は、それ自体が極めて空気酸化されやすいこ
とから、通常では安定保存が困難であり、このことから
も、ゼラチンカプセル内に密封した製品が汎用されてい
る。
2. Description of the Related Art In general, for example, tocopherols (vitamin E) are well known as antioxidants derived from natural products, and are currently widely used as pharmaceuticals, foods or additives thereof. However, since tocopherols are fat-soluble and the substance itself is oily, its use is limited to addition to oils and fats, gelatin capsules and the like. In addition, since a substance exhibiting such an antioxidant action itself is extremely easily oxidized by air, it is usually difficult to store it stably, and therefore, a product sealed in a gelatin capsule is widely used. .

【0003】[0003]

【発明が解決しようとする課題】本発明はトコフェロー
ル類等抗酸化物質が抱える諸問題を解決し、さらに乾燥
末として食品、医薬品ならびにその添加物として利用可
能にすることを意図する。
DISCLOSURE OF THE INVENTION The present invention is intended to solve the problems of antioxidants such as tocopherols and to make the dried powder usable as foods, pharmaceuticals and additives.

【0004】[0004]

【課題を解決するための手段】本発明者は研究の結果、
クロレラ・ブルガリスE25を暗所で従属栄養条件下に
培養した藻体が強い抗酸化力を有し、過酸化脂質の生成
を抑制することを発見し、この発見に基づいて本発明を
完成するに至った。
Means for Solving the Problems As a result of research, the present inventor has
The inventors have found that algal cells cultured with Chlorella vulgaris E25 under heterotrophic conditions in the dark have strong antioxidant power and suppress the production of lipid peroxide, and based on this finding, complete the present invention. Reached.

【0005】本発明は、暗所で従属栄養条件下に培養し
た単細胞緑藻類の藻体もしくはその抽出物よりなる抗酸
化剤に関する。
[0005] The present invention relates to an antioxidant comprising a single-cell green alga alga body or an extract thereof cultured in a dark place under heterotrophic conditions.

【0006】暗所で従属栄養条件下に培養可能な単細胞
緑藻類としては、例えば、クロレラ(Chlorell
a)、クラミドモナス(Chlamydomona
s)、及びセネデスムス(Scenedesmus)に
属するものが挙げられる。
[0006] Unicellular green algae that can be cultured under heterotrophic conditions in the dark include, for example, Chlorella
a), Chlamydomonas
s), and those belonging to Scenedesmus.

【0007】好ましい具体例はクロレラ・ブルガリスE
25で、これは現在、光合成が行われないように完全暗
所において、従属栄養条件下に工業的に培養、市販され
ている(特公昭58−29047、特開平9−2386
94)。
A preferred embodiment is Chlorella vulgaris E
25, which is currently industrially cultured and marketed under heterotrophic conditions in a completely dark place so that photosynthesis does not take place (JP-B-58-29047, JP-A-9-2386).
94).

【0008】培養、採取された本発明の単細胞緑藻類の
藻体は死滅させ又は死滅させずにそのまま又は乾燥物の
形で、あるいは、水もしくは水性溶媒による抽出物、又
はメタノール、エタノール、ヘキサンその他の有機溶媒
による抽出物の形で、抗酸化剤として利用できる。
The cultured and collected algal cells of the single-cell green algae of the present invention may be killed or not killed, or may be used as such or in the form of a dried product, or an extract with water or an aqueous solvent, or a mixture of methanol, ethanol, hexane, and the like. It can be used as an antioxidant in the form of an extract with an organic solvent.

【0009】本発明の単細胞緑藻類に含まれる抗酸化性
物質は乾燥末中においても極めて安定である。
The antioxidant contained in the single-cell green algae of the present invention is extremely stable even in dry powder.

【0010】何故安定なのかその理由を考察すると、ク
ロロフィルは極めて不安定な天然有機色素化合物である
にも拘らず、本発明の単細胞緑藻乾燥末中においては安
定で、暗所であれば数年以上経過しても含有率は低下せ
ず、分解は殆ど行われていない。クロロフィルは酸化分
解もおこし易いことから、本発明の単細胞緑藻乾燥末中
では酸化分解は殆ど行われていないのではないか、した
がって、暗所、従属栄養条件下において培養された単細
胞緑藻乾燥末中には、抗酸化物質が多量に、しかも安定
な形で含まれているのではないかと考えられる。それ
は、実施例の試験において人の血清低密度リポタンパク
質(LDL)に対する抗酸化作用が極めて優れているこ
とからも裏付けられる。
Considering the reason why chlorophyll is stable, chlorophyll is stable in the dry powder of the single-cell green algae of the present invention, even though it is an extremely unstable natural organic pigment compound, and it is stable for several years in the dark. Even after the above, the content did not decrease, and almost no decomposition was performed. Chlorophyll is also susceptible to oxidative degradation, so oxidative degradation is hardly performed in the dried single-cell green algae of the present invention. May contain antioxidants in large amounts and in a stable form. This is supported by the extremely excellent antioxidant effect on human serum low-density lipoprotein (LDL) in the tests of the examples.

【0011】本発明は、安全で食用可能であり粉末の形
でも安定な抗酸化剤として、極めて利用価値の高いもの
で、食品、医薬品、医薬部外品、化粧品ならびに、これ
らの添加物としての広範囲な利用を可能とするものであ
る。
The present invention is extremely useful as an antioxidant which is safe, edible and stable even in the form of powder, and is useful as a food, drug, quasi-drug, cosmetic, and an additive thereof. It is intended to be widely used.

【0012】[0012]

【作用】暗所で従属栄養条件下に培養された単細胞緑藻
においては光合成反応が行われない。したがってその反
応に伴う酸化反応に備えて藻体内に準備された抗酸化物
質が消費されることなく残存する。その抗酸化物質を本
発明は利用するものである。
The photosynthetic reaction does not take place in unicellular green algae cultured under heterotrophic conditions in the dark. Therefore, the antioxidant prepared in the alga body remains without being consumed in preparation for the oxidation reaction accompanying the reaction. The present invention utilizes the antioxidant.

【0013】[0013]

【実施例】実施例 クロレラ・ブルガリスE−25(E−25)の血清低密
度リポタンパク質(LDL)に対する抗酸化作用を試験
した。
EXAMPLES The antioxidant effect of Chlorella vulgaris E-25 (E-25) on serum low density lipoprotein (LDL) was tested.

【0014】(1)試料 クロレラ・ブルガリスE−25乾燥末を蒸留水に10%
(w/v)懸濁し、沸騰湯浴上で20分間加熱、熱水抽
出したものの遠心上清(E−25−W)と、クロレラ・
ブルガリスE−25乾燥末を常温下メタノールに10%
(w/v)懸濁し、10分間攪拌抽出したものの遠心上
清(E−25−M)を試料として用意した。
(1) Sample Chlorella vulgaris E-25 dried powder was added to distilled water at 10%.
(W / v) Suspended, heated on a boiling water bath for 20 minutes, extracted with hot water, centrifuged supernatant (E-25-W), chlorella.
Bulgaris E-25 dried powder in methanol at room temperature 10%
(W / v) Suspended and extracted by stirring for 10 minutes, and a centrifugal supernatant (E-25-M) was prepared as a sample.

【0015】なお抗酸化作用効果を比較するために、試
料無添加の対照区(Control)、ならびに、その
抗酸化作用が知られているα−トコフェロール(VE)
80μモルを含む試験区を設定した。
In order to compare the antioxidant effect, a control group (Control) without addition of a sample and α-tocopherol (VE), whose antioxidant effect is known, are used.
A test plot containing 80 μmol was set.

【0016】(2)方法 健常成人血清より比重分配超遠心分離により分取精製し
た血清低密度リポタンパク質(LDL)の濃度について
は、Sephadex G−25カラム(ファルマシア
製PD−25)によって脱塩処理した各サンプルのLD
L濃度を、含有タンパク質量をMicro BC4 P
rotein Assay Reogent Kit
(PIECE社製)にて測定し、均一にした。本実施例
においては、LDL濃度を含有タンパク質量200μg
/mlに調整したもの1ml中に、上記のように調整し
た試料を最終濃度50倍希釈量となるように加え、酸化
剤として硫酸銅5μモルを添加後、37℃で2.5時間
保温した。これにEDTA0.1mモルを加えて酸化反
応を停止しSephadex G−25カラム(ファル
マシア製PD−25)によって脱塩処理した。
(2) Method The concentration of serum low-density lipoprotein (LDL) fractionated and purified from healthy adult serum by specific gravity ultracentrifugation was desalted using a Sephadex G-25 column (Pharmacia PD-25). LD of each sample
The L concentration and the amount of protein contained in the micro BC4P
protein Assay Reagent Kit
(Manufactured by PIECE) and made uniform. In this example, the LDL concentration was adjusted to 200 μg
In 1 ml of the solution adjusted to / ml, the sample adjusted as described above was added to a final concentration of 50-fold dilution, and 5 μmol of copper sulfate was added as an oxidizing agent, followed by incubation at 37 ° C. for 2.5 hours. . To this was added 0.1 mmol of EDTA to stop the oxidation reaction, and the mixture was desalted with a Sephadex G-25 column (PD-25 manufactured by Pharmacia).

【0017】酸化の程度は過酸化脂質量(LPO)を、
デタミナ−LPOキット(協和メディックス社製)を用
いて測定した。〔この測定手法はヘモグロビンを触媒と
して、ハイドロパーオキサイド(過酸化脂質)とメチレ
ンブルーの誘導体が反応して、メチレンブルーが等モル
生成する現象を利用し、このメチレンブルーの呈色度を
測定することにより過酸化脂質を定量するものであ
る。〕
The degree of oxidation is determined by the amount of lipid peroxide (LPO),
The measurement was performed using a determiner-LPO kit (manufactured by Kyowa Medix). [This measurement technique utilizes the phenomenon in which a derivative of methylene blue reacts with hydroperoxide (lipid peroxide) using hemoglobin as a catalyst to form equimolar methylene blue. It quantifies oxidized lipids. ]

【0018】試料0.1mlにLPO前処理液(アスコ
ルビン酸オキシダーゼ、リポプロテインリパーゼ等含
有)1mlを加え混和後、30℃で5分間静置する。L
PO発色液(メチレンブルー誘導体・MCDP、ヘモグ
ロビン等含有)2mlを加え混和後、30℃で10分間
静置する。このようにして生じるメチレンブルー量を6
75nmの吸光度を用いて定量し、その値から、下記の
計算式を用いて過酸化脂質量を算出した。標準液として
は、cumen hydroperoxide水溶液
(50.0nモル/ml)0.1mlを用いた。 過酸化脂質量(nモル/ml)=Es/Estd×5
0.0 Es:試料の吸光度 Estd:標準液の吸光度 結果を図1に示す。
1 ml of LPO pretreatment solution (containing ascorbate oxidase, lipoprotein lipase, etc.) is added to 0.1 ml of the sample, mixed, and allowed to stand at 30 ° C. for 5 minutes. L
After adding and mixing 2 ml of a PO color developing solution (containing methylene blue derivative, MCDP, hemoglobin, etc.), the mixture is allowed to stand at 30 ° C. for 10 minutes. The amount of methylene blue generated in this way is 6
Quantification was performed using absorbance at 75 nm, and the amount of lipid peroxide was calculated from the value using the following formula. 0.1 ml of aqueous solution of cumene hydroperoxide (50.0 nmol / ml) was used as a standard solution. Lipid peroxide amount (nmol / ml) = Es / Estd x 5
0.0 Es: absorbance of sample Estd: absorbance of standard solution The results are shown in FIG.

【0019】(3)結果および考察 図1から明らかなように、試料を加えていない対照区に
おいては、過酸化脂質量が極めて多くなり、またビタミ
ンEを添加した試験区においては、酸化が抑制されてい
ることが確認された。上記試料を添加した試験区におい
ても、対照区に比較して顕著な酸化抑制が認められ、こ
の酸化抑制効果は、特に熱水抽出したものに多く含まれ
ることが判った。この実験に用いたビタミンEは高純度
(純度99%以上)試薬であり、このビタミンE・80
μモルの効果の約50%の効果がクロレラ・ブルガリス
E−25乾燥末10%(w/v)熱水抽出液に認められ
たことにより、クロレラ・ブルガリスE−25乾燥末が
極めて高い抗酸化作用を有するものと言える。また、メ
タノール抽出液の効果が熱水抽出液ほど顕著でない理由
として、メタノール抽出液の主成分として存在するクロ
ロフィル、カロテノイド等色素類のLDLに対する抗酸
化活性が低いことによるものと考えられる。
(3) Results and Discussion As apparent from FIG. 1, the amount of lipid peroxide was extremely large in the control group where no sample was added, and the oxidation was suppressed in the test group where vitamin E was added. It was confirmed that it was. In the test group to which the above sample was added, remarkable oxidation suppression was observed as compared with the control group, and it was found that this oxidation suppression effect was particularly included in the hot water-extracted samples. Vitamin E used in this experiment was a high-purity (99% or more) reagent.
Chlorella vulgaris E-25 dry powder is extremely high because about 50% of the effect of μmol was observed in 10% (w / v) hot water extract of Chlorella vulgaris E-25 dry powder. It can be said that it has an antioxidant effect. The reason why the effect of the methanol extract is not as remarkable as that of the hot water extract may be due to the low antioxidant activity of pigments such as chlorophyll and carotenoids present as the main components of the methanol extract against LDL.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例における試験において、各試験区毎に、
血清低密度リポタンパク質(LDL)中の過酸化脂質量
を測定比較した棒グラフである。
FIG. 1 In the tests in Examples,
It is a bar graph which measured and compared the amount of lipid peroxide in serum low density lipoprotein (LDL).

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 暗所で従属栄養条件下に培養した単細胞
緑藻類の藻体もしくはその抽出物よりなる抗酸化剤。
An antioxidant comprising a single-cell green alga alga body or an extract thereof cultured in a dark place under heterotrophic conditions.
【請求項2】 単細胞緑藻類がクロレラ、セネデスムス
又はクラミドモナスである請求項1記載の抗酸化剤。
2. The antioxidant according to claim 1, wherein the single-cell green algae is Chlorella, Scenedesmus or Chlamydomonas.
【請求項3】 単細胞緑藻類がクロレラ・ブルガリスで
ある請求項1又は2記載の抗酸化剤。
3. The antioxidant according to claim 1, wherein the single-cell green algae is Chlorella vulgaris.
【請求項4】 単細胞緑藻類がクロレラ・ブルガリスE
25である請求項1、2又は3記載の抗酸化剤。
4. The single-cell green algae is Chlorella vulgaris E.
The antioxidant according to claim 1, 2 or 3, which is 25.
【請求項5】 暗所で従属栄養条件下に培養した単細胞
緑藻類の藻体もしくはその抽出物よりなる過酸化脂質生
成抑制剤。
5. A lipid peroxide production inhibitor comprising a single-cell green algae alga body or an extract thereof cultured in a dark place under heterotrophic conditions.
【請求項6】 単細胞緑藻類がクロレラ、セネデスムス
又はクラミドモナスである請求項5記載の過酸化脂質生
成抑制剤。
6. The lipid peroxide production inhibitor according to claim 5, wherein the single-cell green algae is Chlorella, Scenedesmus or Chlamydomonas.
【請求項7】 単細胞緑藻類がクロレラ・ブルガリスで
ある請求項5又は6記載の過酸化脂質生成抑制剤。
7. The lipid peroxide production inhibitor according to claim 5, wherein the single-cell green algae is Chlorella vulgaris.
【請求項8】 単細胞緑藻類がクロレラ・ブルガリスE
25である請求項5、6又は7記載の過酸化脂質生成抑
制剤。
8. The single-cell green algae is Chlorella vulgaris E.
The lipid peroxide production inhibitor according to claim 5, 6 or 7, which is 25.
JP2000307367A 2000-10-06 2000-10-06 Antioxidant Pending JP2002114703A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000307367A JP2002114703A (en) 2000-10-06 2000-10-06 Antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000307367A JP2002114703A (en) 2000-10-06 2000-10-06 Antioxidant

Publications (1)

Publication Number Publication Date
JP2002114703A true JP2002114703A (en) 2002-04-16

Family

ID=18787895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000307367A Pending JP2002114703A (en) 2000-10-06 2000-10-06 Antioxidant

Country Status (1)

Country Link
JP (1) JP2002114703A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH701253A1 (en) * 2009-06-12 2010-12-15 Mibelle Ag Use of an extract from snow algae in cosmetic or dermatological formulations.
WO2012069073A1 (en) * 2010-11-12 2012-05-31 La Prairie Group Ag Cosmetic and/or dermatological preparations containing extracts of snow algae
DE102014216029A1 (en) * 2013-08-16 2015-03-12 La Prairie Group Ag Preparation for protection against extrinsic and intrinsic skin aging
JP2016514470A (en) * 2013-03-29 2016-05-23 ロケット フレールRoquette Freres Method for stabilizing oxidation-sensitive metabolites produced by microalgae of the genus Chlorella

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09238694A (en) * 1996-03-06 1997-09-16 Yamaki:Kk Production of readily water-soluble chlorophyll

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09238694A (en) * 1996-03-06 1997-09-16 Yamaki:Kk Production of readily water-soluble chlorophyll

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH701253A1 (en) * 2009-06-12 2010-12-15 Mibelle Ag Use of an extract from snow algae in cosmetic or dermatological formulations.
US8206721B2 (en) 2009-06-12 2012-06-26 Mibelle Ag Use of an extract from snow algae in cosmetic or dermatological formulations
WO2012069073A1 (en) * 2010-11-12 2012-05-31 La Prairie Group Ag Cosmetic and/or dermatological preparations containing extracts of snow algae
US20130287714A1 (en) * 2010-11-12 2013-10-31 Sven Gohla Cosmetic and/or dermatological preparations containing snow algae extract
JP2016514470A (en) * 2013-03-29 2016-05-23 ロケット フレールRoquette Freres Method for stabilizing oxidation-sensitive metabolites produced by microalgae of the genus Chlorella
DE102014216029A1 (en) * 2013-08-16 2015-03-12 La Prairie Group Ag Preparation for protection against extrinsic and intrinsic skin aging
US9763873B2 (en) 2013-08-16 2017-09-19 La Prairie Group Ag Preparation for protecting against extrinsic and intrinsic skin aging

Similar Documents

Publication Publication Date Title
Ince et al. The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxidant activity, and DNA damage in rats
Panganamala et al. Differential inhibitory effects of vitamin E and other antioxidants on prostaglandin synthetase, platelet aggregation and lipoxidase
de Oliveira et al. Total phenolic content and free radical scavenging activities of methanolic extract powders of tropical fruit residues
Del Campo et al. Accumulation of astaxanthin and lutein in Chlorella zofingiensis (Chlorophyta)
During et al. Intestinal absorption and metabolism of carotenoids: insights from cell culture
CN101023966A (en) Green algal extract containing astaxanthin having high storage stability
Gharibzahedi et al. Comparison of antioxidant and free radical scavenging activities of biocolorant synthesized by Dietzia natronolimnaea HS-1 cells grown in batch, fed-batch and continuous cultures
Affany et al. Comparison of the protective effect of various flavonoids against lipid peroxidation of erythrocyte membranes (induced by cumene hydroperoxide)
Raspor et al. Prevention of intracellular oxidation in yeast: the role of vitamin E analogue, Trolox (6-hydroxy-2, 5, 7, 8-tetramethylkroman-2-carboxyl acid)
Yurkiv et al. Antioxidant effects of medicinal mushrooms Agaricus brasiliensis and Ganoderma lucidum (higher Basidiomycetes): evidence from animal studies
D'aquino et al. Effect of fish oil and coconut oil on antioxidant defence system and lipid peroxidation in rat liver
Goss et al. Lipid dependence of diadinoxanthin solubilization and de-epoxidation in artificial membrane systems resembling the lipid composition of the natural thylakoid membrane
Dambeck et al. Antioxidative activities of algal keto carotenoids acting as antioxidative protectants in the chloroplast
JPH07112980B2 (en) Active oxygen free radical scavenger
EP1874137A1 (en) Spirulin composition rich in active principles, method for obtaining same and use thereof
JP2002114703A (en) Antioxidant
CA2487693A1 (en) Method for producing preparations rich in tocotrienol
Wang et al. Phototoxicity and DNA damage induced by the cosmetic ingredient chemical azulene in human Jurkat T-cells
Pangestuti et al. Cosmetics and cosmeceutical applications of microalgae pigments
Liu et al. Antioxidant activities of novel galloyl phytosterols evaluated by human erythrocytes with the aid of confocal microscopy imaging
Eke et al. Effect of ingestion of microwaved foods on serum anti-oxidant enzymes and vitamins of albino rats
CN110237105A (en) A kind of potent oxidation resisting soft capsule and preparation method thereof
KR100739437B1 (en) Natural Antioxidant Using Oltmannsiellopsis unicellularis
Toan et al. Effects of Dietary Inclusion of Canthaxanthin‐and α‐Tocopherol‐Loaded Liposomes on Growth and Muscle Pigmentation of Rainbow Trout (Oncorhynchus mykiss)
Spirt et al. Carotenoids in photooxidative stress

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070925

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080730

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110302